Hidden depression in otolaryngology patients with medically unexplained symptoms

Fumiyuki Goto, Tomoko Tsutsumi, Naoki Oishi, Masaru Mimura

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: To investigate the prevalence of depression among otolaryngology patients with medically unexplained symptoms (MUS) and the outcome of treatment with selective serotonin reuptake inhibitors (SSRIs). Method: Ninety patients with MUS from a population of 983 consecutive otolaryngology outpatients were enrolled. The Self-Rating Depression Scale (SDS) was used to screen for depression. In addition to standard treatment, all depressed and nondepressed patients received SSRIs for 8 weeks. The Clinical Global Impression-Improvement (CGI-I) scale was used to evaluate clinical changes in patients with MUS. Results: There were 49 patients with depression among those with MUS, according to the SDS criteria. The patients with depression showed a better outcome than those without depression, demonstrating more significantly improved CGI-I scores. Conclusion: More than half of the individuals with otolaryngological MUS had depression, and their MUS were successfully treated withSSRIs.

Original languageEnglish
Pages (from-to)206-208
Number of pages3
JournalGeneral Hospital Psychiatry
Volume34
Issue number2
DOIs
Publication statusPublished - 2012 Mar

Fingerprint

Otolaryngology
Serotonin Uptake Inhibitors
Medically Unexplained Symptoms
Outpatients
Population

Keywords

  • Antidepressant
  • Depression
  • Medically unexplained symptoms
  • Selective serotonin reuptake inhibitors

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Hidden depression in otolaryngology patients with medically unexplained symptoms. / Goto, Fumiyuki; Tsutsumi, Tomoko; Oishi, Naoki; Mimura, Masaru.

In: General Hospital Psychiatry, Vol. 34, No. 2, 03.2012, p. 206-208.

Research output: Contribution to journalArticle

@article{008b1f6a8fb74674bc4cd868ec8507fa,
title = "Hidden depression in otolaryngology patients with medically unexplained symptoms",
abstract = "Objective: To investigate the prevalence of depression among otolaryngology patients with medically unexplained symptoms (MUS) and the outcome of treatment with selective serotonin reuptake inhibitors (SSRIs). Method: Ninety patients with MUS from a population of 983 consecutive otolaryngology outpatients were enrolled. The Self-Rating Depression Scale (SDS) was used to screen for depression. In addition to standard treatment, all depressed and nondepressed patients received SSRIs for 8 weeks. The Clinical Global Impression-Improvement (CGI-I) scale was used to evaluate clinical changes in patients with MUS. Results: There were 49 patients with depression among those with MUS, according to the SDS criteria. The patients with depression showed a better outcome than those without depression, demonstrating more significantly improved CGI-I scores. Conclusion: More than half of the individuals with otolaryngological MUS had depression, and their MUS were successfully treated withSSRIs.",
keywords = "Antidepressant, Depression, Medically unexplained symptoms, Selective serotonin reuptake inhibitors",
author = "Fumiyuki Goto and Tomoko Tsutsumi and Naoki Oishi and Masaru Mimura",
year = "2012",
month = "3",
doi = "10.1016/j.genhosppsych.2011.09.014",
language = "English",
volume = "34",
pages = "206--208",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Hidden depression in otolaryngology patients with medically unexplained symptoms

AU - Goto, Fumiyuki

AU - Tsutsumi, Tomoko

AU - Oishi, Naoki

AU - Mimura, Masaru

PY - 2012/3

Y1 - 2012/3

N2 - Objective: To investigate the prevalence of depression among otolaryngology patients with medically unexplained symptoms (MUS) and the outcome of treatment with selective serotonin reuptake inhibitors (SSRIs). Method: Ninety patients with MUS from a population of 983 consecutive otolaryngology outpatients were enrolled. The Self-Rating Depression Scale (SDS) was used to screen for depression. In addition to standard treatment, all depressed and nondepressed patients received SSRIs for 8 weeks. The Clinical Global Impression-Improvement (CGI-I) scale was used to evaluate clinical changes in patients with MUS. Results: There were 49 patients with depression among those with MUS, according to the SDS criteria. The patients with depression showed a better outcome than those without depression, demonstrating more significantly improved CGI-I scores. Conclusion: More than half of the individuals with otolaryngological MUS had depression, and their MUS were successfully treated withSSRIs.

AB - Objective: To investigate the prevalence of depression among otolaryngology patients with medically unexplained symptoms (MUS) and the outcome of treatment with selective serotonin reuptake inhibitors (SSRIs). Method: Ninety patients with MUS from a population of 983 consecutive otolaryngology outpatients were enrolled. The Self-Rating Depression Scale (SDS) was used to screen for depression. In addition to standard treatment, all depressed and nondepressed patients received SSRIs for 8 weeks. The Clinical Global Impression-Improvement (CGI-I) scale was used to evaluate clinical changes in patients with MUS. Results: There were 49 patients with depression among those with MUS, according to the SDS criteria. The patients with depression showed a better outcome than those without depression, demonstrating more significantly improved CGI-I scores. Conclusion: More than half of the individuals with otolaryngological MUS had depression, and their MUS were successfully treated withSSRIs.

KW - Antidepressant

KW - Depression

KW - Medically unexplained symptoms

KW - Selective serotonin reuptake inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84857361869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857361869&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2011.09.014

DO - 10.1016/j.genhosppsych.2011.09.014

M3 - Article

VL - 34

SP - 206

EP - 208

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

IS - 2

ER -